Enhancement of hypoxia-activated prodrug TH-302 anti-tumor activity by Chk1 inhibition

por Meng, Fanying, Bhupathi, Deepthi, Sun, Jessica D, Liu, Qian, Ahluwalia, Dharmendra, Wang, Yan, Matteucci, Mark D, Hart, Charles P
Publicado 2015

Efficacy and safety of the hypoxia-activated prodrug TH-302 in combination with gemcitabine and nab-paclitaxel in human tumor xenograft models of pancreatic cancer

por Sun, Jessica D, Liu, Qian, Ahluwalia, Dharmendra, Li, Wenwu, Meng, Fanying, Wang, Yan, Bhupathi, Deepthi, Ruprell, Ayesha S, Hart, Charles P
Publicado 2015